The WACC of Helix Biopharma Corp (HBP.TO) is 7.3%.
| Range | Selected | |
| Cost of equity | 9.40% - 12.50% | 10.95% |
| Tax rate | 25.90% - 26.50% | 26.20% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 6.6% - 8.1% | 7.3% |
| Category | Low | High |
| Long-term bond rate | 3.3% | 3.8% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 1.2 | 1.34 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 9.40% | 12.50% |
| Tax rate | 25.90% | 26.50% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 6.6% | 8.1% |
| Selected WACC | 7.3% | |